Crinetics (CRNX) PT Lowered to $41 at JMP Securities
Tweet
Share
E-mailGet Alerts CRNX Hot Sheet
Price: $84.69 --0%
Rating Summary:
7 Buy, 12 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
7 Buy, 12 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
JMP Securities analyst Jonathan Wolleben lowered the price target on Crinetics (NASDAQ: CRNX) to $41.00 (from $50.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Marti Technologies (MRT) PT Lowered to $3.50 at Roth/MKM
- Futu Holdings Limited (FUTU) PT Raised to $157 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
